Spur Therapeutics
UK - StevenageBiotechnology
Focus: Spur Therapeutics is a UK-based gene therapy biotech focused on protein replacement for rare genetic diseases, operating at the pre-revenue stage with a pipeline targeting hemophilia, Fabry disease, and Gaucher disease.
Profile data last refreshed 44m ago · AI intelligence enriched 1w ago
Open Jobs
3+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Spur Therapeutics?
AI assessmentBest suited for early-career or specialist gene therapy professionals seeking deep technical involvement in a focused rare disease pipeline, with elevated execution risk typical of pre-revenue biotechs.
Why Work Here
- Ground-floor opportunity in an emerging gene therapy platform with 8 active clinical programs across multiple rare disease indications
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)
Hemophilia BClinical Trials (1)
NCT04272554AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)
N/AHelp build intelligence for Spur Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.